Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tofimilast in Adults With Persistent Asthma
NCT00150397Phase 2Completed
- Sponsor
- Pfizer
- Start
- Mar 2005
- Primary completion
- Nov 2005
- Modality
- Small Molecules
- Countries
- 3
01
Overview
Phase 2, randomised, double-blind trial in asthma comparing Tofimilast with Placebo (2 arms). Primary endpoint: Change from baseline in Forced Expiratory Volume in 1 second. Started Mar 2005; status: completed.
02
Drugs
tofimilast
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00150397.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00150397.